renalweb.groupee.net
RenalWEB Discussion Forums
Administration / Financial / Strategic
Administrative/Financial Issues
William Venus of DPA brings good news on ESRD drug reimbursement
Topic Closed|
Go
![]() |
New
![]() |
Find
![]() |
Notify
![]() |
Tools
![]() |
Everyone, William Venous of Dialysis Purchasing Alliance has forwarded good news concerning miscalculations in the drug reimbursement by CMS for 2006. If the NRAA-GPO is not working for you, DPA is an alternative dedicated to working on behalf of independent ESRD providers.
"GOOD NEWS, if you have not already received this email. Dialysis Purchasing Alliance William Venus Managing Director wvenus@dpagpo.com 5500 New Horizons Blvd N. Amityville, NY 11701 tel: 800-372-4002 x6901 fax: 631-789-6901 -----Original Message----- From: CMS CMSProviderResource [mailto:CMSProviderResource@CMS.HHS.GOV] Sent: Thursday, September 01, 2005 4:25 PM To: ESRD-L@LIST.NIH.GOV Subject: Correction to the Proposed ESRD Drug Add-on Adjustment Published in the Federal Register, August 8, 2005 Correction to the Proposed ESRD Drug Add-on Adjustment Published in the Federal Register, August 8, 2005 ESRD industry representatives have brought to our attention an error in the estimation of the market shares for the top ten ESRD drugs that we used in our calculation of the proposed drug add-on adjustment for 2006. After an analysis of the 2003 expenditure data used to assign weights to the top ten ESRD drugs, we determined that our data did not appropriately account for three �J� code changes that were implemented in 2003. As a result the total expenditures for Iron Sucrose, Sodium Ferric Gluconate, and Calcitriol were understated. In addition, the weight for EPO incorrectly included expenditures for hospital-based facilities. Since the purpose of the weighting was to allocate the drug spread to all other drugs paid using the proposed ASP+6% pricing, hospital-based data should not have been included because we had proposed to continue paying for other hospital-based facility drugs based on cost. The attached table shows the revised weights compared to the weights included in the proposed rule. Using these revised weights, the proposed recalculated 2005 drug add-on adjustment should be 10.4 percent, and the proposed 2006 update should be 0.8 percent. The correct total drug add-on adjustment proposed for 2006 is 11.3 percent. We note that for the final rule we intend to use more recent 2004 billing data to compute the final drug add-on adjustment for 2006. Related Links: �Correction to the Proposed ESRD Drug Add-on Adjustment: Revised Table 22� is available at http://www.cms.hhs.gov/providers/esrd/090105_ESRD_Correction.pdf (CMS-1502-CN) Correction notice to the Physician Fee NPRM ; Correction Notice published September 1, 2005 http://www.cms.hhs.gov/physicians/pfs/1502pcor_notice.pdf (CMS-1502-P) Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2006; Proposed Rule published August 8, 2005 http://www.cms.hhs.gov/providerupdate/regs/cms1502P.pdf Additional ESRD information is available at http://www.cms.hhs.gov/providers/esrd/ and http://www.cms.hhs.gov/providers/esrd.asp on the CMS website." Thank you Mr. Venus Sincerely, Joe Atkins |
|||
|
| Previous Topic | Next Topic | powered by eve community |
| Please Wait. Your request is being processed... |
Topic Closed
renalweb.groupee.net
RenalWEB Discussion Forums
Administration / Financial / Strategic
Administrative/Financial Issues
William Venus of DPA brings good news on ESRD drug reimbursement
